[Therapy selection in patients with advanced bladder cancer. Is molecular biology helpful?].

Der Urologe. Ausg. A
K JunkerMichael Stöckle

Abstract

The prognosis of patients with advanced bladder cancer is still limited by a high rate of systemic progression. In addition to extended lymph node dissection, perioperative chemotherapy has been shown to improve the outcome after cystectomy. The role of neoadjuvant and adjuvant therapies are still a matter of controversial debate: there is an overtreatment of patients on the one hand but other patients are undertreated and do not receive chemotherapy because the progression risk may be underestimated on the basis of clinical and histopathological parameters. Improved cure rates can be achieved by new biomarkers defining the individual risk of systemic progression and predicting the response probability of the individual patient.A number of recent publications demonstrated that molecular signatures of the primary tumor can define the metastatic risk or correlate with chemotherapy response. Furthermore, it is essential to understand resistance mechanisms and to develop new targeted therapies based on knowledge of bladder tumor biology. This paper gives an overview concerning the role of molecular biology for therapy decision-making.

References

Jan 13, 2001·Oncogene·Q WangM I Greene
May 10, 2003·The Journal of Biological Chemistry·Suniti MisraBryan P Toole
Aug 20, 2004·Human Molecular Genetics·Miquel TaronJose Maestre
Nov 18, 2004·Journal of the National Cancer Institute·Richard D KennedyD Paul Harkin
Apr 9, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ryo TakataYusuke Nakamura
Jun 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan LehmannUNKNOWN AUO-AB 05/95
Jan 20, 2006·Genome Biology·Dawid EckertHubert Schorle
Jun 17, 2006·Advances in Anatomic Pathology·Mohammed AkhtarStephen Rohan
Jul 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN International Bladder Cancer Nomogram ConsortiumKinjal C Vora
Jan 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntUNKNOWN Spanish Oncology Genitourinary Group
Mar 3, 2007·International Journal of Cancer. Journal International Du Cancer·Johanna M Pellikainen, Veli-Matti Kosma
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George SimonGerold Bepler
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manuel CoboRafael Rosell
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer E QuinnD Paul Harkin
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liana AdamColin Dinney
Nov 3, 2009·Neoplasia : an International Journal for Oncology Research·Dmytro M HavaleshkoDan Theodorescu
Jul 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A FontR Rosell
Aug 7, 2010·Neoplasia : an International Journal for Oncology Research·Andreas-Claudius HoffmannArndt Hartmann
Jan 25, 2011·The Lancet Oncology·Steven Christopher SmithDan Theodorescu
Mar 18, 2011·International Journal of Cancer. Journal International Du Cancer·Sameer DhayatJoerg Haier
Jun 28, 2011·International Journal of Cancer. Journal International Du Cancer·Ruth L VinallRalph W deVere White
Aug 5, 2011·Current Opinion in Urology·Yuanbin RuDan Theodorescu
Sep 24, 2011·Journal of Ovarian Research·Smriti KumarSham S Kakar
Sep 29, 2011·Clinical Epigenetics·Kristy R KutanziIgor P Pogribny

❮ Previous
Next ❯

Citations

Jan 1, 2013·ISRN Nephrology·Konstantin N KonstantinovAntonios H Tzamaloukas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.